Skip to content
ClinCalc Pro
Menu
Sympathomimetic (alpha + beta agonist)

Adrenaline (epinephrine)

Brand names: EpiPen, Emerade, Jext

Adrenaline (epinephrine) is an endogenous catecholamine used in emergency care, principally in cardiac arrest and as a vasopressor in shock, and intramuscularly in anaphylaxis.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is a potent agonist at alpha- and beta-adrenergic receptors, producing vasoconstriction, increased myocardial contractility and heart rate, and bronchodilation.

Prescribing in practice

  • Different clinical situations require very different concentrations and routes, so the correct strength must be confirmed against the indication, as confusion between intramuscular anaphylaxis and intravenous cardiac-arrest preparations can be fatal.
  • In cardiac arrest it is given intravenously or intraosseously during CPR per the resuscitation algorithm; as a peripheral vasopressor infusion it risks extravasation and tissue necrosis.
  • Effects are exaggerated in patients on non-selective beta-blockers or tricyclic antidepressants and it may provoke arrhythmias and severe hypertension.

Monitoring

Continuous ECG, blood pressure and, for infusions, invasive arterial and central access monitoring with frequent checks of the infusion site are required.

Counselling the patient

  • Confirm the indication-specific concentration and route before administration.
  • Give vasopressor infusions through a central line where feasible to limit extravasation injury.
  • Document timing of doses against the resuscitation cycle.

Evidence & guidelines

Adrenaline is recommended in Resuscitation Council UK advanced life support algorithms for cardiac arrest and as a first-line agent in anaphylaxis.

Reference: Resuscitation Council UK 2021; NICE CG134; MHRA DSU on auto-injectors; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.